AFS
OVID icon

Annapolis Financial Services’s Ovid Therapeutics OVID Stock Holding History

Annapolis Financial Services’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,000
Closed -$17K – 494
2021
Q3 		$17K Hold
5,000
– – 0.01% 255
2021
Q2 		$20K Hold
5,000
– – 0.01% 218
2021
Q1 		$20K Buy
+5,000
New +$16.6K 0.01% 206

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Annapolis Financial Services's OVID Position: Q4 2021 in Review

Annapolis Financial Services sold out of Ovid Therapeutics (OVID) in Q4 2021, closing a stake of 5,000 shares — an estimated $17K sold.

Annapolis Financial Services first reported a position in OVID in Q1 2021 and held it in 3 quarters. The position peaked at $20K in Q2 2021. 67 funds tracked by Wall St. Rank hold OVID as of Q4 2021.

  • Annapolis Financial Services reported no remaining Ovid Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Annapolis Financial Services sold 5,000 Ovid Therapeutics shares in Q4 2021, an estimated $17K.
  • Annapolis Financial Services first reported a position in Ovid Therapeutics in Q1 2021 and held it in 3 quarters.
  • Annapolis Financial Services's Ovid Therapeutics position peaked at $20K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2021.

Based on Annapolis Financial Services's 13F filing for Q4 2021, filed 11 Feb 2022.